Company news
Xilio Therapeutics, Inc. news in 2026
Xilio Therapeutics, Inc.'s news releases, calls and decks from 2026, newest first.
Xilio Therapeutics to Present at the Stifel 2026 Healthcare Conference
November 3, 2026
Xilio Therapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of XTX501 in Patients with Metastatic NSCLC
October 26, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 2, 2026
Xilio Therapeutics Appoints Yariv J. Houvras, M.D., Ph.D. as Chief Medical Officer
September 28, 2026
Xilio Therapeutics Reports Second Quarter 2026 Financial Results and Provides Pipeline and Business Updates
August 12, 2026
Xilio Therapeutics Appoints Ben Harshbarger as Chief Legal Officer
June 29, 2026
Xilio Therapeutics Reports First Quarter 2026 Financial Results and Provides Pipeline and Business Updates
May 12, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 7, 2026
May 11, 2026
Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 7, 2026
Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
April 17, 2026
Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors
April 15, 2026
Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2025 Financial Results
March 22, 2026
Xilio Therapeutics to Present New Preclinical Data for its Masked T Cell Engager Program Targeting CLDN18.2 at the American Association for Cancer Research (AACR) Annual Meeting
March 17, 2026
Xilio Therapeutics Announces 1-for-14 Reverse Stock Split
March 11, 2026
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
March 2, 2026
Xilio Therapeutics Announces Pricing of Underwritten Offering
February 11, 2026
Xilio Therapeutics Highlights Upcoming Milestones and Recent Corporate Updates
January 8, 2026
Decks in 2026
- Investor Presentation (March 2026)
Investor deck · 36 slides · Mar 9, 2026